Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8744815 | Clinical Microbiology and Infection | 2018 | 18 Pages |
Abstract
rCDI is a significant challenge for healthcare professionals, requiring a multifaceted approach; optimized infection control to minimize reinfection; C. difficile-targeted antibiotics to minimize dysbiosis; and gut microflora restoration to promote colonization resistance. These elements should be informed by our understanding of the microbiologic factors involved in both C. difficile itself and the gut microbiome.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
C.H. Chilton, D.S. Pickering, J. Freeman,